Hernia Repair in Multiply Morbid Patients

ClinicalTrials.gov ID: NCT00930787

Public ClinicalTrials.gov record NCT00930787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Randomized, Controlled, Single-Blinded Study of Strattice Reconstructive Tissue Matrix vs Proceed

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Support of a ventral hernia repair with a prosthetic mesh has been demonstrated to result in a diminished rate of hernia recurrence. The patient with co-morbidities undergoing hernia repair is at increased risk of wound related complications, which may be exacerbated by the choice of prosthetic mesh, and which are known to influence the ultimate rate of hernia recurrence. It is hypothesized that patients receiving a mesh of biologic origin may experience fewer wound related complications and hence at least an equal rate of hernia recurrence, compared to those receiving a synthetic mesh.

Study identification

NCT ID: NCT00930787
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 4
Lead sponsor: LifeCell; Industry
Enrollment: 23 participants

Conditions and interventions

Conditions

Ventral Hernia

Interventions

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2009 (Type not available)
Primary completion: May 2010 (Actual)
Completion: May 2010 (Actual)
Last update posted: Nov 20, 2013

2009 – 2010

United States locations

U.S. sites: 13
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
Louisiana Status University Health Sciences Center	New Orleans	Louisiana	70112	—
Tulane University	New Orleans	Louisiana	70115	—
University of Maryland Medical Center	Baltimore	Maryland	21201	—
University of Maryland	Baltimore	Maryland	21201	—
Boston Veterans Administration Healthcare System	West Roxbury	Massachusetts	02132	—
Hurley Medical Center	Flint	Michigan	48503	—
Mayo Clinic	Rochester	Minnesota	55905	—
Truman Medical Center	Kansas City	Missouri	64108	—
Long Island Jewish - North Shore	Lake Success	New York	11042	—
University Hospital - Case Western	Cleveland	Ohio	44106	—
Oregon Health Sciences University	Portland	Oregon	97239	—
University of Texas - MD Anderson Cancer Center	Houston	Texas	70115	—
Scott & White Medical Center	Temple	Texas	76508	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00930787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 20, 2013 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00930787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →